Medimmune
  • ABOUT MEDIMMUNE
    • Key Facts & Figures
    • Products
    • Facilities
    • At the Forefront
  • OUR CULTURE
    • History & Highlights
    • Visionaries at MedImmune
    • Executive Team
    • Corporate Responsibility
  • R & D
    • Pipeline
    • Drug Phase Chart
    • Biologics
    • Technologies & Approaches
    • Partnering
  • VENTURES
    • Investing in Our Future
    • Portfolio
  • PRESS ROOM
  • CAREERS
  • CONTACT
  • Home >
    • News & Media

News and Media

For press releases:

2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999

Receive E-mail alerts

Subscribe to RSS feeds

December 17, 2002
FDA Advisory Committee Recommends Approval For Medimmune’s FlumistTM To Prevent Influenza
October 24, 2002
MedImmune Reports Results for 2002 Third Quarter and Nine Month Period
October 18, 2002
Phase 3 Study Shows Synagis(R) Reduces RSV Hospitalization in Young Children with Congenital Heart Disease
October 8, 2002
MedImmune to Announce Third Quarter 2002 Financial Results On October 24, 2002
August 26, 2002
MedImmune Responds To FluMistTM Complete Response Letter
August 15, 2002
MedImmune Licenses Rights To Newly Discovered Human Metapneumovirus
July 25, 2002
MedImmune Reports Results For First Six Months Of 2002
July 24, 2002
MedImmune Announces Three New Executive Appointments
July 19, 2002
MedImmune Forms $100 Million Venture Capital Fund
July 11, 2002
MedImmune Receives Complete Response Letter From FDA For Flumist™, An Intranasal Flu Vaccine
June 28, 2002
MedImmune To Announce Second Quarter 2002 Financial Results On July 25, 2002
June 6, 2002
MedImmune Breaks Ground for New Headquarters
May 28, 2002
MedImmune’s Synagis® Approved in Canada
May 15, 2002
MedImmune Files Quarterly Report on Form 10-Q for First Quarter 2002
April 25, 2002
MedImmune Reports Record Revenues for First Quarter 2002
April 18, 2002
MedImmune To Announce First Quarter 2002 Financial Results On April 25, 2002
April 18, 2002
MedImmune Licenses Two New Cancer Technologies
April 18, 2002
MedImmune Finalizes Plans For New Headquarters
February 21, 2002
MedImmune Announces Executive Promotion and Appointments
February 21, 2002
MedImmune Names Elizabeth Wyatt to Board of Directors
January 24, 2002
MedImmune Reports 2001 Fourth Quarter and Year-End Results
January 24, 2002
MedImmune's Synagis(R) Approved in Japan
January 21, 2002
MedImmune to Announce 2001 Fourth Quarter and Year End Financial Results on January 24, 2002
January 15, 2002
MedImmune Completes Aviron Acquisition
January 10, 2002
MedImmune Acquires Aviron Shares in Exchange Offer
January 9, 2002
MedImmune Registration Statement for Aviron Acquisition Declared Effective
January 4, 2002
MedImmune Receives Antitrust Clearance for Aviron Acquisition
  • Terms and Conditions
  • |
  • Privacy Policy
  • |
  • Site Map
  • |
  • Contact Us
  • |
  • Glossary
Copyright © 2009 MedImmune, LLC. All rights reserved.